Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: A retrospective analysis

Pediatric Transplantation

Volumn 10, Issue 3, 2006, Pages 331-336

  Benz, Kerstin ^a   Plank, Christian ^a   Griebel, Martin ^b   Montoya, Carmen ^b   Dötsch, Jörg ^a   Klare, Bernd ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Kinderklinik Schwabing   (Germany)

Author keywords

Cyclosporine A nephrotoxicity; Cyclosporine A reduction; Mycophenolate mofetil; Pediatric kidney transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MONOTHERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS;

EID: 33646234000     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00475.x     Document Type: Article

References (24)

1. McDonald R Donaldson L Emmett L Tejani A A decade of living donor transplantation in North American children the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Pediatr Transplant 2000 4 221 234
2. Bennett WM DeMattos A Meyer MM Andoh T Barry JM Chronic cyclosporine nephropathy in renal transplantation Transplant Proc 1996 28 2100 2103
3. Weir MR Ward MT Blahut SA et al Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy Kidney Int 2001 59 1567 1573
4. Weir MR Blahut S Drachenburg C et al Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function Am J Nephrol 2004 24 379 386
5. Filler G Gellermann J Zimmering M Mai I Effect of adding mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity Transpl Int 2000 13 201 206
6. David-Neto E Araujo LM Lemos FC et al Introduction of mycophenolate mofetil and cyclosporine reduction in children with chronic transplant nephropathy Pediatr Transplant 2001 5 302 309
7. Henne T Latta K Strehlau J Pape L Ehrich JH Offner G Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy Transplantation 2003 76 1326 1330
8. Klare B Montoya CR Griebel M Stangl M Schneeberger H Land W Verbessertes Patienten- und Transplantatüberleben im Kindesalter mit meist normaler Endgröße bei 20-jähriger steroid-freier Immunsuppression Tx medizin 2004 16 178 187
9. Schwartz GJ Haycock GB Edelmann CM Jr. Spitzer A A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Pediatrics 1976 58 259 263
10. Soergel M Kirschstein M Busch C et al Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents a multicenter trial including 1141 subjects J Pediatr 1997 130 178 184
11. Gonzalez Molina M Seron D Garcia del Moral R et al Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy Transplantation 2004 77 215 220
12. Pape L Froede K Strehlau J Ehrich JHH Offner G Alterations of cyclosporin A metabolism induced by mycophenolate mofetil Pediatr Transplant 2003 7 302 304
13. Abramowicz D Manas D Cyclosporine Withdrawal Study Group et al Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients a randomized, controlled study Transplantation 2002 74 1725 1734
14. Myers BD Sibley R Newton L et al The long-term course of cyclosporine-associated chronic nephropathy Kidney Int 1988 33 590 600
15. Rice JE Shipp AT Carlin JB Vidmar SI Weintraub RG Late reduction in cyclosporine dosage does not improve renal function in pediatric heart transplant recipients J Heart Lung Transplant 2002 21 1109 1112
16. Mourad G Vela C Ribstein J Mimran A Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy Transplantation 1998 65 661 667
17. Quarto Di Palo F Castagnone D Rivolta R et al Cyclosporine renal cortical vasoconstriction measured by colour Doppler imaging in kidney transplantation Transplant Int 1992 5 21 22
18. Pascual M Curtis J Delmonico FL et al A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation Transplantation 2003 75 1501 1505
19. de Mattos AM Olyaei AJ Bennett WM Nephrotoxicity of immunosuppressive drugs long-term consequences and challenges for the future Am J Kidney Dis 2000 35 333 346
20. English RF Pophal SA Bacanu SA et al Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients Am J Transplant 2002 2 769 773
21. Flechner SM Kurian SM Solez K et al De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years Am J Transplant 2004 4 1776 1785
22. Ruiz JC Campistol JM Mota A et al Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions Transplant Proc 2003 35 1669 1670
23. Saunders RN Bicknell GR Nicholson ML The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy Transplantation 2003 75 772 780
24. Hoyer PF Ettenger R Everolimus Pediatric Study Group et al Everolimus in pediatric de nova renal transplant patients Transplantation 2003 75 2082 2085